Activation of the JAK-STAT3 pathway is associated with the growth of colorectal carcinoma cells

Oncology Reports

Volumn 31, Issue 1, 2014, Pages 335-341

  Wei, Xubin ^a   Wang, Gang ^a   Li, Wei ^a   Hu, Xupang ^a   Huang, Qinghong ^a   Xu, Ke ^a   Lou, Wenjia ^a   Wu, Jia ^a   Liang, Chen ^a   Lou, Qibin ^a   Qian, Chen ^a   Liu, Li ^a  

^a ZHEJIANG SCI TECH UNIVERSITY   (China)

Author keywords

Colorectal carcinoma; Inflammation; JAK STAT3; Oncolytic adenoviral vector; SOCS3

Indexed keywords

ADENOVIRUS VECTOR; JANUS KINASE; ONCOLYTIC ADENOVIRUS; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GENE THERAPY; CANCER GROWTH; CANCER INHIBITION; CELL STRAIN HCT116; CELL STRAIN HT29; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SOCS3 GENE;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL NEOPLASMS; FEMALE; HCT116 CELLS; HEK293 CELLS; HT29 CELLS; HUMANS; JANUS KINASES; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; ONCOLYTIC VIRUSES; PHOSPHORYLATION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 84891929666     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2858     Document Type: Article

References (24)

1. Flossmann E and Rothwell PM: Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 369: 1603-1613, 2007.
2. Wu S, Rhee KJ, Albesiano E, et al: A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 15: 1016-1022, 2009.
3. Mantovani A, Allavena P, Sica A and Balkwill F: Cancer-related inflammation. Nature 454: 436-444, 2008.
4. Yu H, Pardoll D and Jove R: STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9: 798-809, 2009.
5. Yasukawa H, Sasaki A and Yoshimura A: Negative regulation of cytokine signaling pathways. Annu Rev Immunol 18: 143-164, 2000.
6. Yoshimura A, Nishinakamura H, Matsumura Y and Hanada T: Negative regulation of cytokine signaling and immune responses by SOCS proteins. Arthritis Res Ther 7: 100-110, 2005.
7. Yu LJ, Wu ML, Li H, et al: Inhibition of STAT3 expression and signaling in resveratrol-differentiated medulloblastoma cells. Neoplasia 10: 736-744, 2008.
8. Calvisi DF, Ladu S, Gorden A, et al: Ubiquitous activation of Ras and Jak/Stat pathways in human HCC. Gastroenterology 130: 1117-1128, 2006.
9. Niwa Y, Kanda H, Shikauchi Y, et al: Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma. Oncogene 24: 6406-6417, 2005.
10. Cui Q, Jiang W, Wang Y, et al: Transfer of suppressor of cytokine signaling 3 by an oncolytic adenovirus induces potential antitumor activities in hepatocellular carcinoma. Hepatology 47: 105-112, 2008.
11. Zhao L, Gu J, Dong A, et al: Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer. Hum Gene Ther 16: 845-858, 2005.
12. Pei Z, Chu L, Zou W, et al: An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice. Hepatology 39: 1371-1381, 2004.
13. Tsareva SA, Moriggl R, Corvinus FM, et al: Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction. Neoplasia 9: 279-291, 2007.
14. Corvinus FM, Orth C, Moriggl R, et al: Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia 7: 545-555, 2005.
15. Karim R, Tse G, Putti T, Scolyer R and Lee S: The significance of the Wnt pathway in the pathology of human cancers. Pathology 36: 120-128, 2004.
16. Calvert PM and Frucht H: The genetics of colorectal cancer. Ann Intern Med 137: 603-612, 2002.
17. Allgayer H: Molecular regulation of urokinase-receptor gene expression as one potential concept for molecular staging and therapy. Recent Results Cancer Res 162: 15-30, 2003.
18. Takeda K, Kaisho T, Yoshida N, Takeda J, Kishimoto T and Akira S: Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J Immunol 161: 4652-4660, 1998.
19. Lutticken C, Wegenka UM, Yuan J, et al: Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science 263: 89-92, 1994.
20. Akira S: Roles of STAT3 defined by tissue-specific gene targeting. Oncogene 19: 2607-2611, 2000.
21. Ihle JN: The Stat family in cytokine signaling. Curr Opin Cell Biol 13: 211-217, 2001.
22. Joliot A and Prochiantz A: Transduction peptides: from technology to physiology. Nat Cell Biol 6: 189-196, 2004.
23. Mae M and Langel U: Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery. Curr Opin Pharmacol 6: 509-514, 2006.
24. Rivera AA, Wang M, Suzuki K, et al: Mode of transgene expression after fusion to early or late viral genes of a conditionally replicating adenovirus via an optimized internal ribosome entry site in vitro and in vivo. Virology 320: 121-134, 2004.